z-logo
open-access-imgOpen Access
Idebenone – a new drug for patients with Leber's hereditary optic neuropathy
Author(s) -
Dorota Szumny,
Karolina Czajor,
Małgorzata Mulak
Publication year - 2021
Publication title -
ophtha therapy
Language(s) - English
Resource type - Journals
eISSN - 2543-9987
pISSN - 2353-7175
DOI - 10.24292/01.ot.300321.3
Subject(s) - idebenone , leber's hereditary optic neuropathy , optic neuropathy , medicine , drug , disease , pediatrics , ophthalmology , pharmacology , optic nerve
Leber's Hereditary Optic Neuropathy is a rare disease caused by a mutation in the mitochondrial DNA. It appears most often in young men, leading to profound, permanent loss of vision in a short time. There is no specific treatment for this condition.Idebenone is a medicine that administered to patients with Leber's hereditary optic neuropathy improves or stops the deterioration of vision. Increasing the number of people during therapy and the duration of treatment will allow in the future to answer the question, whether this drug is effective and safe in a larger group of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here